Investigating the effect of an education program on diabetes and lipid lowering medication usage following coronary artery bypass graft surgery.
Sarah A HitchenNick Si Rui LanUmar S AliAdam L HortR LarbalestierBu B YeapP Gerry FeganPublished in: Internal medicine journal (2021)
The intervention did not improve inpatient glycaemia or increase non-statin lipid-lowering prescriptions in patients with diabetes following CABG surgery but did reduce reliance on specialty input. Initiation of SGLT2 inhibitor therapy near time of hospital discharge was not associated with safety concerns. Alternative interventions or strategies are required to optimise glycaemia and non-statin lipid-lowering therapy prescribing in this setting. This article is protected by copyright. All rights reserved.
Keyphrases
- coronary artery bypass
- percutaneous coronary intervention
- cardiovascular disease
- coronary artery disease
- healthcare
- fatty acid
- randomized controlled trial
- primary care
- type diabetes
- minimally invasive
- physical activity
- palliative care
- mental health
- adverse drug
- emergency department
- acute coronary syndrome
- coronary artery bypass grafting
- quality improvement
- insulin resistance
- surgical site infection
- weight loss